BioPharm International - September 2022

BioPharm International - September 2022

Issue link:

Contents of this Issue


Page 2 of 37

2 BioPharm International ® Emerging Therapies 2022 eBook BioPharm I N T E R N AT I O N A L eBook T h e S ci e n ce & B usi n e ss o f B i o p h a r m a ce u t i c a ls FOUNDER Mike Hennessy Sr 1960 - 2021 © 2022 MultiMedia Pharma Sciences LLC All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical including by photocopy, recording, or information storage and retrieval without permission in writing from the publisher. Authorization to photocopy items for internal/educational or personal use, or the internal/ educational or personal use of specific clients is granted by MultiMedia Pharma Sciences LLC for libraries and other users registered with the Copyright Clearance Center, 222 Rosewood Dr. Danvers, MA 01923, 978-750-8400 fax 978-646-8700 or visit online. For uses beyond those listed above, please direct your written request to with "Permissions" in the subject line. Reprints: Contact Michael Tracey, MultiMedia Pharma Sciences LLC provides certain customer contact data (such as customers' names, addresses, phone numbers, and e-mail addresses) to third par ties who wish to promote relevant products, services, and other opportunities that may be of interest to you. If you do not want MultiMedia Pharma Sciences LLC to make your contact information available to third parties for marketing purposes, simply email and a customer service representative will assist you in removing your name from MultiMedia Pharma Sciences LLC lists. BioPharm International does not verify any claims or other information appearing in any of the advertisements contained in the publication, and cannot take responsibility for any losses or other damages incurred by readers in reliance of such content. BioPharm International welcomes unsolicited articles, manuscripts, photographs, illustrations, and other materials but cannot be held responsible for their safekeeping or return. To subscribe, email ADVERTISING Publisher Mike Tracey National Sales Manager Scott Vail European Sales Manager Linda Hewitt European Senior Sales Executive Stephen Cleland Executive Vice President, Healthcare and Industry Sciences Brian Haug AUDIENCE DEVELOPMENT Audience Development Stacy Argondizzo MJH LIFE SCIENCES TM President & CEO Mike Hennessy Jr Chief Financial Officer Neil Glasser, CPA/CFE Chief Operating Officer Michael Ball Chief Marketing Officer Brett Melillo Executive Vice President, Global Medical Affairs & Corporate Development Joe Petroziello Senior Vice President, Content Silas Inman Vice President, Human Resources and Administration Shari Lundenberg Vice President, Mergers & Acquisitions Chris Hennessy Executive Creative Director Jeff Brown EDITORIAL Editorial Director Chris Spivey Senior Editor Felicity Thomas Senior Editor Meg Rivers Managing Editor Susan Haigney Science Editor Feliza Mirasol Assistant Editor Grant Playter Assistant Editor Alivia Leon Contributing editors: Jill Wechsler, Cynthia A. Challener, Jennifer Markarian Creative Director, Publishing Melissa Feinen Senior Art Director Marie Maresco Senior Graphic Designer Maria Xelo Cover: ChristophBurgstedt - DEVELOPMENT Accelerating the Development of mRNA Therapeutics Scott Ripley 4 Treating Cancer with Oncolytic Viruses Meg Rivers 10 MANUFACTURING Real-Time Post-Apheresis Documentation Decreases Errors Julie Tilbury 14 The Road to Personalized Medicine: Reimagining Drug Manufacturing Matt Hewitt 18 ANALYTICS Shining a Light on Lipid Nanoparticle Characterization Hanna Jankevics Jones and Natalia Markova 22 QUALITY/REGULATIONS Novel Therapies of 2022 Grant Playter 26 BIOBUSINESS Biotech Incubators Cultivate a Global Scene Feliza Mirasol 28 Pfizer's Idea Orchard Chris Spivey 34 AD INDEX 36 Emerging Therapies 2022 Contents

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm International - September 2022 - BioPharm International - September 2022